Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2018 Publisher: Pharmaco (NZ) Ltd, 4 Fisher Crescent, Mount Wellington, Auckland 1060, New Zealand. PO Box 4079, Auckland 1140, New Zealand. Free Phone: 0800 804 079.
ALCAINE TM proxymetacaine hydrochloride Eye Drops 0.5%.
| Pharmaceutical Form |
|---|
|
Sterile preserved eye drops, solution. |
Alcaine Eye Drops contain the active ingredient proxymetacaine hydrochloride 0.5% (5 mg/mL).
Excipient with known effect: Benzalkonium chloride 0.1 mg in 1 mL as a preservative.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Proparacaine |
Proxymetacaine is a potent topical anaesthetic of the ester type. The main site of anaesthetic action is the nerve cell membrane where proxymetacaine interferes with the large transient increase in the membrane permeability to sodium ions that is normally produced by a slight depolarisation of the membrane. |
| List of Excipients |
|---|
|
Benzalkonium chloride 0.1 mg in 1 mL as a preservative |
Alcaine Eye Drops come in a 15 mL, dropper bottle consisting of a low density polyethylene.
Pharmaco (NZ) Ltd, 4 Fisher Crescent, Mount Wellington, Auckland 1060, New Zealand.
PO Box 4079, Auckland 1140, New Zealand.
Free Phone: 0800 804 079.
12 July 2018
| Drug | Countries | |
|---|---|---|
| ALCAINE | Canada, Cyprus, Ecuador, Estonia, Hong Kong, Lithuania, New Zealand, Poland, Singapore, Turkey, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
